Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology

4358 - Detection of frailty in elderly colorectal càncer patients: is G8 a good screening tool?

Date

21 Oct 2018

Session

Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology

Topics

Cancer in Older Adults

Tumour Site

Colon and Rectal Cancer

Presenters

Gemma Soler

Citation

Annals of Oncology (2018) 29 (suppl_8): viii150-viii204. 10.1093/annonc/mdy281

Authors

J.C. Ruffinelli Rodriguez1, G. Soler2, R. Legido2, M. Martinez Villacampa1, F.J. Perez1, B. Pardo-Burdalo3, J.A. Marín1, I. Morilla Ruiz2, L. Heras Lopez3, S. Vazquez1, S. Recalde1, M. Plana Serrahima2, C. Santos1, N. Mulet Margalef1, A. Teule4, R. Salazar1, M.C. Galan1, J. Saldaña1

Author affiliations

  • 1 Medical Oncology, Institut Català d'Oncologia Hospital Duran i Reynals, 08907 - Barcelona/ES
  • 2 Medical Oncology, Institut Català d'Oncologia Hospital Duran i Reynals, 8907 - Barcelona/ES
  • 3 Medical Oncology, Institut Català d'Oncologia Hospital Duran i Reynals, Barcelona/ES
  • 4 Medical Oncology, Institut Català d'Oncologia Hospital Duran i Reynals, 8026 - Barcelona/ES

Resources

Login to access the resources on OncologyPRO.

If you do not have an ESMO account, please create one for free.

Abstract 4358

Background

Colorectal cancer (CRC) is one of the most commonly diagnosed cancers. About one half of cases are diagnosed in patients over 70 years of age. A multidimensional geriatric assessment is recommended in older patients but requires considerable time and resources. The aim of this study was to explore whether the G8 questionnaire to identify frailty may be helpful in decision-making in older CCR patients.

Methods

From October 2015 to July 2017, 142 patients over 75 years old were included prospectively. All the patients were assessed on four scales: G8, Pfeiffer, Barthel and TIRS scale, in addition to assessing age, comorbidity and functional status. Positive screening was performed for those older than 85 years, and those younger than 85 with 2 criteria (G8 ≤14, Pfeiffer > 2, Barthel < 90 and TIRS +).

Results

The median age was 80.4 years (75.1 – 88.9). 45% had metastatic disease. 82% had G8 score≤14; 38% decided not to be treated with chemotherapy. 62% were treated with chemotherapy (47% capecitabine, 11% FOLFOX6 and 4% in a clinical trial). 43 % of the patients with G8≤14 started treatment with adapted doses and 39% at subsequent cycles. Of the G8> 14, only 28% were reduced at the beginning and 14% at subsequent cycles. Grade 3/4 toxicities in the G8≤14 versus G8>14. were: plantar palmar syndrome 14.3% vs 0%; hematological 15% vs 0%; gastrointestinal 18% vs 14%; mucositis 3.6% vs 0%; asthenia 11% vs 0%; and renal failure 4% vs 0%.

Conclusions

The G8 questionnaire helps to discriminate which patients are candidates for chemotherapy. If the G8 score is ≤ 14, it supports the decision to reduce the dose and it predicts toxicity. This suggests that G8 could be an instrument that detects frailty in older patients with CRC with the intention of undergoing systemic treatment. After analyzing these results, it is recommended to perform a complete geriatric assesment in these patients to validate our conclusions.

Clinical trial identification

Legal entity responsible for the study

Gemma Soler.

Funding

Has not received any funding.

Editorial Acknowledgement

Disclosure

All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.